Analytical Data
-
Gene name
SPATS2
- Application
-
Alternative Names
SPATA10; SCR59; p59scr; Serine-rich spermatocytes and round spermatid 59 kDa protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86XZ4
-
Expression Region
Trp81~Ser385
-
Molecular Weight
48kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPATS2 (Sperm-associated antigen 2) is a protein primarily expressed in the male reproductive system, particularly in spermatozoa and testicular tissues. Its involvement in sperm maturation and function has garnered significant interest in reproductive biology. Recent studies have suggested that SPATS2 may play a crucial role in male fertility, potentially influencing sperm motility and acrosome reaction, which are essential for successful fertilization. The study of SPATS2 as a recombinant protein has become increasingly relevant in understanding its biological functions and potential applications in reproductive medicine. By producing SPATS2 in a recombinant form, researchers can investigate its structural properties and interactions with other proteins, paving the way for the development of diagnostic tools or therapeutic strategies for male infertility. Moreover, understanding the molecular mechanisms underlying SPATS2's involvement in sperm function could lead to novel approaches in contraception or enhancement of assisted reproductive technologies. Given the rising prevalence of male infertility worldwide, research into proteins like SPATS2 is critical for advancing our knowledge of male reproductive health and unlocking potential avenues for treatment.
